Analysis of the Glyco-Code in Pancreatic Ductal Adenocarcinoma Identifies Glycan-Mediated Immune Regulatory Circuits

By analysing publicly available transcriptomic data of patient samples and cell lines, researchers identified here two specific glycan profiles in pancreatic ductal adenocarcinoma that correlated with progression, clinical outcome and epithelial to mesenchymal transition status.